Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Justine Bednorz

Appendix 3B – New Issue Announcement

7 January 2019 by Justine Bednorz

Appendix 3B – New Issue Announcement

Categories 2019, ASX Announcements

Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial

7 August 2018 by Justine Bednorz

Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial

Categories 2018, ASX Announcements

New Issue Oversubscribed

12 June 2018 by Justine Bednorz

New Issue Oversubscribed

Categories 2018, ASX Announcements

Quarterly Report 31 December 2017

16 January 2018 by Justine Bednorz

Quarterly Report 31 December 2017

Categories 2018, ASX Announcements, Quarterly Reports

Biotron Compounds Demonstrate Activity Against Hepatitis B Virus

15 November 2017 by Justine Bednorz

Biotron Compounds Demonstrate Activity Against Hepatitis B Virus

Categories 2017, ASX Announcements

Annual report for the year ended 30 June 2017

20 October 201718 October 2017 by Justine Bednorz

Annual Report for the year ended 30 June 2017

Categories Annual Reports

Quarterly Report 30 September 2017

18 October 2017 by Justine Bednorz

Quarterly Report 30 September 2017

Categories Quarterly Reports

Annual Report and Notice of AGM

18 October 2017 by Justine Bednorz

Annual Report and Notice of AGM

Categories 2017, ASX Announcements

Appendix 4C

18 October 2017 by Justine Bednorz

Appendix 4C

Categories 2017, ASX Announcements

Year End Accounts and Preliminary Final Report

29 August 2017 by Justine Bednorz

Year End Accounts and Preliminary Final Report

Categories 2017, ASX Announcements
Older posts
Page1 Page2 … Page12 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 6 June 2025        Legal Notices and Privacy
Cleantalk Pixel